Comparison of antibody responses to different forms of HIV-1 core antigens by epitope mapping

Journal of Medical Virology

Volumn 51, Issue 3, 1997, Pages 145-151

  Truong, Catherine ^a   Brand, Denys ^a   Mallet, François ^b   Roingeard, Philippe ^a   Barin, Francis ^a  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

core precursor; epitopes; HIV 1; virion assembly; virus like particles

Indexed keywords

CORE PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MOUSE; NONHUMAN; VIRUS ASSEMBLY; VIRUS PARTICLE; VISION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 0030981004     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199703)51:3<145::AID-JMV2>3.0.CO;2-6     Document Type: Article

References (23)

1. Brand D, Mallet F, Truong C, Roingeard P, Goudeau A, Barin F (1995): A simple procedure to generate chimeric p55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1. Journal of Virological Methods 51:153-168.
2. Carpio E, Duarte C, Hinkula J, Broliden PA, Rosen J, Campal A, Gavilondo J, Wahren B, Jondal M (1991): Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2. AIDS Research and Human Retroviruses 7:97-101.
3. Carrière C, Gay B, Chazal N, Morin N, Boulanger P (1995): Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 gag precursor into retrovirus-like particles. Journal of Virology 69:2366-2377.
4. Cheynet V, Verrier B, Mallet F (1993): Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification. Protein Expression and Purification 4:367-372.
5. Henderson LE, Bowerts MA, Sowder RC, Serabyn SA, Johnson DG, Bess JW, Arthur LO, Bryant DK, Fenselau C (1992): Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: Posttranslational modifications, proteolytic processings and complete amino acid sequences. Journal of Virology 66: 1856-1865.
6. Janvier B, Archinard P, Mandrand B, Goudeau A, Barin F (1990): Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2. Journal of Virology 64:4258-4263.
7. Janvier B, Mallet F, Cheynet V, Dalbon P, Vernet G, Besnier JM, Choutet P, Goudeau A, Mandrand B, Barin F (1993): Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes 6:898-903.
8. Janvier B, Lasarte JJ, Sarobe P, Hoebeke J, Baillou-Beaufils A, Borras-Cuesta F, Barin F (1996): B-cell epitopes of HIV-1 p24 capsid protein: A reassessment. AIDS Research and Human Retroviruses 12:519-525.
9. Javaherian K, Langlois AJ, Larosa GJ, Profy AT, Bolognesi D, Herlihy WC, Putney SD, Matthews TJ (1990): Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 250:1590-1593.
10. Larosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, Lewis JA, Langlois AJ, Dreesman GR, Boswell RN, Shadduck P, Holley H, Karplus M, Bolognesi DP, Matthews TJ, Emini EA, Putney SD (1990): Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 233:209-212.
11. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Bermann P, Gregory T, Capon DJ (1987): Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
12. Mabrouk K, Benjouad A, Gluckman JC, Rochat H, Van Rietschoten J, Bahraoui E (1992): Specificity of anti-p25 antibodies produced against whole HIV-1 particles or soluble forms of the protein Molecular Immunology 29:1309-1381.
13. Mathiesen T, Broliden PA, Rosen J, Wahren B (1989): Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides. Immunology 67:453-459.
14. Matsuo K, Nishino Y, Kimura T, Yamaguchi R, Yamakazi A, Mikami T, Ikuta K (1992): Highly conserved epitope domain in major core protein p24 is structurally similar among human, simian and feline immunodeficiency viruses. Journal of General Virology 73: 2445-2450.
15. Matthews S, Barlow P, Boyd J, Barton G, Russel R, Mills H, Cunningham M, Meyers N, Burns N, Clark N, Kingsman S, Campbell I (1994): Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ. Nature 370:666-668.
16. Moriarty AM, McGee JS, Winslow BJ, Inman DW, Leturcq DJ, Thornton GB, Hughes JL, Milich DR (1990): Expression of HIV gag and env B-cell epitopes on the surface of HBV core particles and analysis of the immune responses generated to those epitopes. In Brown F, Chanock RM, Ginsberg HS, Lerner RA (eds): "Vaccines 90. Modern Approaches to New Vaccines Including Prevention of AIDS." New York: CSH Press, pp 225-229.
17. Niedrig M, Hinkula J, Weigelt WL, L'Age-Stehr J, Pauli G, Rosen J, Wahren B (1989): Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides. Journal of Virology 63:3525-3528.
18. Rao Z, Belyaev AS, Fry E, Roy P, Jones IM, Stuart DI (1995): Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378:743-747.
19. Schödel F, Moriarty AM, Peterson DL, Zheng J, Hughes JL, Will H, Leturcq D, McGee JS, Milich DR (1992): The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. Journal of Virology 66:106-114.
20. Truong C, Brand D, Mallet F, Roingeard P, Brunet S, Barin F (1996): Assembly and immunogenicity of chimeric gag-env proteins derived from the human immunodeficiency virus type 1. AIDS Research and Human Retroviruses 12:291-301.
21. Turbica I, Posner M, Bruck C, Barin F (1995): Simple enzyme immunoassay for titration of antibodies to the CD4-binding site of human immunodeficiency virus type 1 gp120. Journal of Clinical Microbiology 33:3319-3323.
22. Veronese F, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG (1988): Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. Journal of Virology 62:795-801.
23. Wahren B, Rosen J, Sandström E, Mathiesen T, Modrow S, Wigzell H (1989): HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. Journal of Acquired Immune Deficiency Syndromes 4:448-456.